These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 9475310)
1. Leukocyte counts in patients with Kawasaki disease: from the results of nationwide surveys of Kawasaki disease in Japan. Koyanagi H; Yanagawa H; Nakamura Y; Yashiro M Acta Paediatr; 1997 Dec; 86(12):1328-32. PubMed ID: 9475310 [TBL] [Abstract][Full Text] [Related]
2. Serum C-reactive protein levels in patients with Kawasaki disease: from the results of nation-wide surveys of Kawasaki disease in Japan. Koyanagi H; Yanagawa H; Nakamura Y; Yashiro M Acta Paediatr; 1997 Jun; 86(6):613-9. PubMed ID: 9202797 [TBL] [Abstract][Full Text] [Related]
3. [Predicting value of thrombospondin-2 for coronary artery dilatation in patients with Kawasaki disease]. Song RX; Li XH; Zhang T; Cui XD; Fu J Zhonghua Er Ke Za Zhi; 2016 Apr; 54(4):259-63. PubMed ID: 27055423 [TBL] [Abstract][Full Text] [Related]
4. Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Nakamura Y; Yashiro M; Uehara R; Watanabe M; Tajimi M; Oki I; Ojima T; Sonobe T; Yanagawa H Pediatr Int; 2004 Feb; 46(1):33-8. PubMed ID: 15043662 [TBL] [Abstract][Full Text] [Related]
5. Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan. Kuwabara M; Yashiro M; Kotani K; Tsuboi S; Ae R; Nakamura Y; Yanagawa H; Kawasaki T J Epidemiol; 2015; 25(3):189-93. PubMed ID: 25716055 [TBL] [Abstract][Full Text] [Related]
6. Incidence of Kawasaki disease in Japan: the nationwide surveys of 1999-2002. Yanagawa H; Nakamura Y; Yashiro M; Uehara R; Oki I; Kayaba K Pediatr Int; 2006 Aug; 48(4):356-61. PubMed ID: 16911079 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018. Ae R; Makino N; Kosami K; Kuwabara M; Matsubara Y; Nakamura Y J Pediatr; 2020 Oct; 225():23-29.e2. PubMed ID: 32454114 [TBL] [Abstract][Full Text] [Related]
8. Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. Yanagawa H; Yashiro M; Nakamura Y; Kawasaki T; Kato H Pediatrics; 1995 Apr; 95(4):475-9. PubMed ID: 7700743 [TBL] [Abstract][Full Text] [Related]
9. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Yanagawa H; Nakamura Y; Yashiro M; Ojima T; Tanihara S; Oki I; Zhang T Pediatrics; 1998 Dec; 102(6):E65. PubMed ID: 9832593 [TBL] [Abstract][Full Text] [Related]
10. Relationship between mean platelet volume-to-lymphocyte ratio and coronary artery abnormalities in Kawasaki disease. Bozlu G; Karpuz D; Hallioglu O; Unal S; Kuyucu N Cardiol Young; 2018 Jun; 28(6):832-836. PubMed ID: 29656728 [TBL] [Abstract][Full Text] [Related]
11. Iv gamma globulin treatment of Kawasaki disease in Japan: results of a nationwide survey. Yanagawa H; Yashiro M; Nakamura Y; Sakata K; Kawasaki T Acta Paediatr; 1995 Jul; 84(7):765-8. PubMed ID: 7549294 [TBL] [Abstract][Full Text] [Related]
12. [Study on the epidemiological features of Kawasaki disease in Jiangsu]. Wang D; Hu B; Wang F; Zhang T; Liu C Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Apr; 21(2):94-6. PubMed ID: 11860763 [TBL] [Abstract][Full Text] [Related]
13. Increasing incidence of Kawasaki disease in Japan: nationwide survey. Nakamura Y; Yashiro M; Uehara R; Oki I; Kayaba K; Yanagawa H Pediatr Int; 2008 Jun; 50(3):287-90. PubMed ID: 18533938 [TBL] [Abstract][Full Text] [Related]
14. Update of the epidemiology of Kawasaki disease in Japan--from the results of 1993-94 nationwide survey. Yanagawa H; Nakamura Y; Yashiro M; Ojima T; Koyanagi H; Kawasaki T J Epidemiol; 1996 Sep; 6(3):148-57. PubMed ID: 8952219 [TBL] [Abstract][Full Text] [Related]
15. Hospital facilities available to patients with Kawasaki disease: results of a national survey of Kawasaki disease in Japan. Koyanagi H; Nakamura Y; Yashiro M; Yanagawa H Acta Paediatr Jpn; 1996 Dec; 38(6):562-6. PubMed ID: 9002287 [TBL] [Abstract][Full Text] [Related]
16. [Epidemiological and clinical characteristics of Kawasaki disease in Shanxi province]. Jiao F; Yang L; Qiao J; Li Y; Zhang T; Liu C Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Apr; 21(2):97-9. PubMed ID: 11860764 [TBL] [Abstract][Full Text] [Related]
17. Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006. Nakamura Y; Yashiro M; Uehara R; Oki I; Watanabe M; Yanagawa H J Epidemiol; 2008; 18(4):167-72. PubMed ID: 18635901 [TBL] [Abstract][Full Text] [Related]
18. Cardiac sequelae of Kawasaki disease in Japan over 10 years. Hirose K; Nakamura Y; Yanagawa H Acta Paediatr Jpn; 1995 Dec; 37(6):667-71. PubMed ID: 8775548 [TBL] [Abstract][Full Text] [Related]
19. Cardiac sequelae of Kawasaki disease in Japan: statistical analysis. Nakamura Y; Fujita Y; Nagai M; Yanagawa H; Imada Y; Okawa S; Kawasaki T; Kato H Pediatrics; 1991 Dec; 88(6):1144-7. PubMed ID: 1720235 [TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease. Kwon H; Lee JH; Jung JY; Kwak YH; Kim DK; Jung JH; Chang I; Kim K Eur J Pediatr; 2016 Dec; 175(12):1997-2003. PubMed ID: 27798729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]